For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240614:nRSN5358Sa&default-theme=true
RNS Number : 5358S Threadneedle Asset Mgmt Hldgs Ltd 14 June 2024
FOR IMMEDIATE RELEASE
14(th) June 2024
XP POWER LIMITED
DEALINGS DISCLOSURE ANNOUNCEMENT BY AMERIPRISE FINANCIAL, INC.
Pursuant to Rule 12.1 of the Singapore Code on Take-overs and Mergers (the Nature of Dealing Number of Shares Dealing Price (GBP £)
"Code"), Ameriprise Financial, Inc. announces the following dealing in the
ordinary shares/financial instruments of XP Power Limited (the "Shares") on
the following dates (the "Dealing"): Date of Dealing
22 May 2024 - ordinary shares Sale 1,209 16.82
29 May 2024 - ordinary shares Sale 1,403 15.76
30 May 2024 - ordinary shares Sale 4,396 15.57
31 May 2024 - ordinary shares Purchase 12,135 15.48
31 May 2024 - ordinary shares Purchase 18,440 15.50
31 May 2024 - ordinary shares Sale 12,135 15.48
11 June 2024 - ordinary shares Transfer out 32,839 0
11 June 2024 - ordinary shares Transfer in 32,839 0
12 June 2024 - ordinary shares Purchase 780 15.96
12 June 2024 - ordinary shares Purchase 5,999 15.78
13 June 2024 - ordinary shares Purchase 1,220 15.76
After the Dealing reported above, Ameriprise Financial, Inc., on behalf of
its various affiliates and subsidiaries which act as investment manager and
therefore have investment discretion over certain funds and accounts,
holds 1,866,535 Shares representing approximately 7.88% per cent. of the
total Shares in issue*.
For any queries in the delay of reporting the above dealing disclosures,
please contact ben.lyon@columbiathreadneedle.com
*The percentage shareholding is computed based on a total of 23,681,754 Shares
(excluding treasury shares) as at 13(th) June 2024 and rounded to the nearest
two (2) decimal places.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END ACQGPUGWQUPCGUC